Endoscopic Sleeve Gastroplasty (ESG) Prospective Trial for Obesity (EGO-Trial)

Prior treatment

• Patients who have started medication in the last 3 months that is known to cause weight gain.
• Patients who are currently excluded (as determined by a previous or ongoing study).

Other illness

• Patients with active peptic ulcer disease or significant gastroparesis
• Patients with a history of bariatric, gastric, or esophageal surgery.
• Patients with a history of uncontrolled, poorly controlled, or suspected eating disorders or psychiatric illness.

Age

• Patients who are pregnant, breastfeeding, or of childbearing age and not using effective contraception.

Other

• Patients with contraindications to endoscopic gastroplasty
• Patients with unstable and precarious health, as determined and assessed by the investigator.
• Patients under judicial protection.
• Patients under guardianship, conservatorship or subject to any form of protective supervision

• Patients aged 18 to 75 years.
• Patients with a Body Mass Index (BMI) ≥ 30 kg/m².
• Patients who have failed non-surgical weight loss interventions (diet, exercise, pharmacological therapy).
• Patients not eligible for bariatric surgery or does not wish to undergo it.
• Patients who can undergo general anesthesia.
• Patients who are able to participate in all aspects of the study and agree to comply with all study requirements for the entire duration of the study.
• Patients who are able to fully understand the study and are willing to give their consent to participate in the study.
• Patients affiliated with the French social security system.